| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/23/2006 | US20060040293 Method for detecting the risk of and for treatment of type 2 diabetes |
| 02/23/2006 | US20060040292 Tumor markers and uses thereof |
| 02/23/2006 | US20060040291 Method for enumerating mammalian cell micronuclei with an emphasis on differentially staining micronuclei and the chromatin of dead and dying cells |
| 02/23/2006 | US20060040290 Methods, compositions, and kits comprising PNA for RNA interference |
| 02/23/2006 | US20060040289 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/23/2006 | US20060040288 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases |
| 02/23/2006 | US20060040287 Method and system for quantifying random errors and any spatial-intensity trends present in microarray data sets |
| 02/23/2006 | US20060040286 Bio-barcode based detection of target analytes |
| 02/23/2006 | US20060040285 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 02/23/2006 | US20060040284 TMS1 compositions and methods of use |
| 02/23/2006 | US20060040283 Methods of manipulating nucleic acids |
| 02/23/2006 | US20060040282 Oligonucleotide sizing using cleavable primers |
| 02/23/2006 | US20060040281 Polyhydroxybutyrate polymerase |
| 02/23/2006 | US20060040280 Functionalized materials and methods of using same |
| 02/23/2006 | US20060040279 DNA chips used for bioprocess control |
| 02/23/2006 | US20060040278 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer |
| 02/23/2006 | US20060040277 Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications |
| 02/23/2006 | US20060040276 Molecular recognition at surfaces derivatized with self-assembled monolayers |
| 02/23/2006 | US20060040275 C-shaped probe |
| 02/23/2006 | US20060040273 Method and apparatus for magnetic sensing and control of reagents |
| 02/23/2006 | US20060040272 Composition comprising library of double stranded nucleic acids |
| 02/23/2006 | US20060040271 Processes for detecting or quantifying more than one nucleic acid in a library |
| 02/23/2006 | US20060040270 Processes for detecting or quantifying more than one nucleic acid in library |
| 02/23/2006 | US20060040269 Cytotoxic factors for modulating cell death |
| 02/23/2006 | US20060040268 Nucleotide sequences specific to Francisella tularensis and methods for the detection of Francisella tularensis |
| 02/23/2006 | US20060040267 Transcriptional activator |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060040264 Means for identifying neisseria meningitidis-specific genes |
| 02/23/2006 | US20060040263 Marker at the androgen receptor gene for determining breast cancer susceptibility |
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/23/2006 | US20060040261 Primers for isothermal amplification of hepatitis C virus |
| 02/23/2006 | US20060040260 Composition and method for monitoring in vitro conversion of full -length mammalian prion protein to amyloid form with physical properties of PRPsc |
| 02/23/2006 | US20060040259 Administering an inhibitor of prenyl cysteine methyltransferase; inhibiting the prenylation or a post-prenylation reaction of a protein contained in the virus infecting a subject |
| 02/23/2006 | US20060040258 Water-soluble conjugates and methods of preparation |
| 02/23/2006 | US20060040257 Immunoassay for HIV protease inhibitors |
| 02/23/2006 | US20060040256 Purifying testosterone from test sample by turbulent flow liquid chromatography; ionizing; detection of 2,2,4,6,6-d5 testosterone by spectrum analysis |
| 02/23/2006 | US20060040255 Cell line designated KT-1 established from tongue epithelial and use thereof |
| 02/23/2006 | US20060040254 Evaluate drugs capable of inhibiting the vanilloid receptor; establish a relaxed bronchial base line state; expose tissue to a dose of a contraction effective agent causing first tensioned state; expose tissue to the candidate substance; allow to return to a base line state |
| 02/23/2006 | US20060040253 Use of Smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney |
| 02/23/2006 | US20060040252 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof |
| 02/23/2006 | US20060040251 Portable medical measurement device and method |
| 02/23/2006 | US20060040250 G-protein coupled receptor fusion protein is modified to include one or more sets of serine/threonine clusters, which enhance binding of such GPCR to arrestin; screening for GPCR ligands, agonists and/or antagonists |
| 02/23/2006 | US20060040249 Screening method involving transfected primary cells |
| 02/23/2006 | US20060039941 Nucleic acid sequences from Drosophila melanogaster that encode proteins essential for viability and uses thereof |
| 02/23/2006 | US20060039927 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039907 Method and compositions for treating diseases targeting CD71 |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | US20060039884 Baldness related gene and the polypeptide encoded thereby , and uses |
| 02/23/2006 | US20060039863 Use of cyanine dyes for the diagnosis of disease associated with angiogenesis |
| 02/23/2006 | US20060039858 Radiolabeled antibodies and peptides for treatment of tumors |
| 02/23/2006 | US20060037870 Electrochemical sensor |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004039628A1 Trägerplatte zur Durchführung funktioneller Tests an biologischen Zellen sowie Verfahren zur Beschichtung der Trägerplatte Carrier plate for carrying out functional tests on biological cells, and methods for coating the carrier plate |
| 02/23/2006 | DE102004025696A1 Ultra-high parallel analysis process to analyse nucleic acid chains in which a sample solid is bound and substrate material |
| 02/23/2006 | DE102004025695A1 Optical fluorescent parallel process to analyse nucleic acid chains in which a sample solid is bound with a primer-matrix complex |
| 02/23/2006 | DE102004025694A1 Optical fluorescent ultra-high parallel process to analyse nucleic acid chains in which a sample solid is bound with a primer-matrix complex |
| 02/23/2006 | CA2777686A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/23/2006 | CA2577623A1 Methods of diagnosis or detection using three-dimensional analysis |
| 02/23/2006 | CA2577260A1 Detection of bacteria in fluids |
| 02/23/2006 | CA2577250A1 Cytochrome p450 induction assay |
| 02/23/2006 | CA2577176A1 Method of screening for a carnitine transporter agonist or antagonist and its uses |
| 02/23/2006 | CA2577165A1 Oral killed vaccines and method for providing same |
| 02/23/2006 | CA2576912A1 Method of detecting thyroid cancer |
| 02/23/2006 | CA2576904A1 Method for rapid identification of microorganisms |
| 02/23/2006 | CA2576870A1 Methods and kits for assaying myeloperoxidase by means of enzymatic glycolate-glyoxylate cycling reactions |
| 02/23/2006 | CA2576431A1 Point source diffusion cell activity assay apparatuses and methods |
| 02/23/2006 | CA2576381A1 Amplification methods |
| 02/23/2006 | CA2574831A1 Biomarkers for bladder cancer |
| 02/23/2006 | CA2574727A1 Biomarkers of neurodegenerative disease |
| 02/23/2006 | CA2574706A1 Salivary transcriptome diagnostics |
| 02/23/2006 | CA2573998A1 Cleavable solid phases for isolating nucleic acids |
| 02/23/2006 | CA2573989A1 Methods of using cleavable solid phases for isolating nucleic acids |
| 02/23/2006 | CA2573905A1 Compositions and methods for releasing nucleic acids from solid phase binding materials |
| 02/23/2006 | CA2557829A1 Catalytic production of biomarkers from biological materials |
| 02/23/2006 | CA2556981A1 Method for detecting and quantifying rare mutations or polymorphisms |
| 02/22/2006 | EP1628135A1 Method for detecting medically relevant conditions in a solubilized LBC sample |
| 02/22/2006 | EP1628129A1 Sensor-receiving container |
| 02/22/2006 | EP1627927A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/22/2006 | EP1627926A1 A method to reduce false positive results |
| 02/22/2006 | EP1627925A1 Method for the determination of cellular transcriptional regulation by micro RNAs |
| 02/22/2006 | EP1627924A1 Method for the analysis of methylated DNA |
| 02/22/2006 | EP1627923A1 Means and methods for detecting and/or staging a follicular lymphoma cells |
| 02/22/2006 | EP1627922A1 Method of screening for a carnitine transporter agonist or antagonist and its uses |
| 02/22/2006 | EP1627921A1 Method for detecting nucleic acid amplification in real-time comprising positioning a reaction vial relative to a detection unit |
| 02/22/2006 | EP1627915A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these |
| 02/22/2006 | EP1627910A1 Apparatus for culturing organism and culture method |
| 02/22/2006 | EP1627686A1 Method for acceleration and intensification of target-receptor binding and device therefor |
| 02/22/2006 | EP1627230A1 Predicting cancer progression |
| 02/22/2006 | EP1627228A1 Method and testing system for analyzing and/or detecting biomolecules and/or active substances in liquid samples |
| 02/22/2006 | EP1627225A2 Improved methods for protein interaction determination |
| 02/22/2006 | EP1627217A2 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 02/22/2006 | EP1627083A2 Systems and methods for determining cell type composition of mixed cell populations using gene expression signatures |
| 02/22/2006 | EP1627082A2 Method and kit for identifying antibiotic-resistant microorganisms |
| 02/22/2006 | EP1627081A2 Use of jag2 expression in diagnosis of plasma cell disorders |
| 02/22/2006 | EP1627080A2 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 02/22/2006 | EP1627079A2 High-throughput methods of screening dna for deletions and other mutations |
| 02/22/2006 | EP1627078A1 Method for the covalent immobilisation of probe biomolecules on organic surfaces |
| 02/22/2006 | EP1627077A1 Susceptibility gene for alzheimer's disease |